Financial Statements

6. Scope of Consolidation; Subsidiaries and Affiliates

6.1 Changes in the Scope of Consolidation

Changes in the scope of consolidation in 2013 were as follows:

Change in Number of Consolidated Companies[Table 4.22]
Germany Other countries Total
Bayer AG and consolidated companies
December 31, 2012 63 227 290
Changes in scope of consolidation 1 3 4
Additions 3 7 10
Retirements (2) (13) (15)
December 31, 2013 65 224 289
2012 figures restated

The decrease in the number of consolidated companies in 2013 was primarily due to mergers among Group companies.

The Bayer Group holds 100% of the voting rights in the fully consolidated subsidiary Bayer Pearl Polyurethane ­Systems LLC, United Arab Emirates, pursuant to a contractual agreement with the non-controlling stockholders.

Texas Brine Company LLC, United States, is fully consolidated as a structured entity. The Bayer Group guarantees the ­liabilities of Texas Brine Company LLC to banks. These liabilities, which are reflected in full in the consolidated statement of financial position, amounted to €22 million as of December 31, 2013 (2012: €27 million).

The above table includes two (2012: two) joint operations, Indurisk Rückversicherung AG, Luxembourg, and Lyondell Bayer Manufacturing Maasvlakte VOF, Netherlands, as of December 31, 2013. Pursuant to IFRS 11, Bayer’s shares of these companies’ assets, liabilities, revenues and expenses are included in the consolidated financial statements in ­accordance with Bayer’s rights and obligations. The main purpose of Lyondell Bayer Manufacturing Maasvlakte VOF is the joint production of propylene oxide (PO) for Bayer and its partner Lyondell.

Two (2012: two) associated companies and three (2012: three) joint ventures are accounted for in the consolidated ­financial statements using the equity method. Details of these companies are given in Note [19].

A total of 79 (2012: 86) subsidiaries, including one (2012: 0) structured entity and 14 (2012: 14) associates or joint ­ventures that in aggregate are immaterial to the Bayer Group’s financial position and results of operations are not consolidated but recognized at cost. The immaterial subsidiaries accounted for less than 0.3% of Group sales, less than 0.3% of equity and less than 0.2% of total assets.

Details of subsidiary and affiliated companies pursuant to Section 313 of the German Commercial Code can be ­accessed at www.annualreport2013.bayer.com/en/companylist.pdfx.

The following domestic subsidiaries availed themselves in 2013 of certain exemptions granted under Section 264 ­Paragraph 3 and Section 264b of the German Commercial Code regarding the preparation, auditing and publication of financial statements:

German Exempt Subsidiaries[Table 4.23]
Company Name Place of Business Bayer’s interest
%
AgrEvo Verwaltungsgesellschaft mbH Frankfurt am Main, Germany 100
Bayer 04 Immobilien GmbH Leverkusen, Germany 100
Bayer 04 Leverkusen Fußball GmbH Leverkusen, Germany 100
Bayer Altersversorgung GmbH Leverkusen, Germany 100
Bayer Animal Health GmbH Leverkusen, Germany 100
Bayer Beteiligungsverwaltung Goslar GmbH Leverkusen, Germany 100
Bayer Business Services GmbH Leverkusen, Germany 100
Bayer Chemicals AG Leverkusen, Germany 100
Bayer Consumer Care Deutschland GmbH Berlin, Germany 100
Bayer CropScience AG Monheim am Rhein, Germany 100
Bayer CropScience Deutschland GmbH Langenfeld, Germany 100
Bayer Direct Services GmbH Leverkusen, Germany 100
Bayer Gastronomie GmbH Leverkusen, Germany 100
Bayer Gesellschaft für Beteiligungen mbH Leverkusen, Germany 100
Bayer HealthCare AG Leverkusen, Germany 100
Bayer Innovation GmbH Leverkusen, Germany 100
Bayer Intellectual Property GmbH Monheim am Rhein, Germany 100
Bayer MaterialScience AG Leverkusen, Germany 100
Bayer MaterialScience Customer Services GmbH Leverkusen, Germany 100
Bayer MaterialScience GmbH Darmstadt, Germany 100
Bayer MaterialScience Oldenburg GmbH & Co. KG Oldenburg, Germany 100
Bayer Real Estate GmbH Leverkusen, Germany 100
Bayer Schering Pharma AG Berlin, Germany 100
Bayer Technology Services GmbH Leverkusen, Germany 100
Bayer Vital GmbH Leverkusen, Germany 100
Bayer Weimar GmbH und Co. KG Weimar, Germany 100
Bayer-Handelsgesellschaft mit beschränkter Haftung Leverkusen, Germany 100
Chemion Logistik GmbH Leverkusen, Germany 100
Dritte Bayer Real Estate VV GmbH & Co. KG Schönefeld, Germany 100
Dritte K-W-A Beteiligungsgesellschaft mbH Leverkusen, Germany 100
Epurex Films GmbH & Co. KG Bomlitz, Germany 100
Erste Bayer Real Estate VV GmbH & Co. KG Schönefeld, Germany 100
Erste K-W-A Beteiligungsgesellschaft mbH Leverkusen, Germany 100
Euroservices Bayer GmbH Leverkusen, Germany 100
Fünfte Bayer Real Estate VV GmbH & Co. KG Schönefeld, Germany 100
Generics Holding GmbH Leverkusen, Germany 100
GP Grenzach Produktions GmbH Grenzach-Wyhlen, Germany 100
Hild Samen GmbH Marbach am Neckar, Germany 100
Intendis GmbH Berlin, Germany 100
Intraserv GmbH & Co. KG Schönefeld, Germany 100
Jenapharm GmbH & Co. KG Jena, Germany 100
KOSINUS Grundstücks-Verwaltungsgesellschaft mbH & Co. Gamma OHG Schönefeld, Germany 100
KVP Pharma+Veterinär Produkte GmbH Kiel, Germany 100
Marotrast GmbH Jena, Germany 100
MENADIER Heilmittel GmbH Berlin, Germany 100
Schering-Kahlbaum Gesellschaft mit beschränkter Haftung Berlin, Germany 100
Sechste Bayer Real Estate VV GmbH & Co. KG Schönefeld, Germany 100
Siebte Bayer VV GmbH Leverkusen, Germany 100
Steigerwald Arzneimittelwerk GmbH Darmstadt, Germany 100
TECTRION GmbH Leverkusen, Germany 100
TravelBoard GmbH Leverkusen, Germany 100
Vierte Bayer Real Estate VV GmbH & Co. KG Schönefeld, Germany 100
Zweite Bayer Real Estate VV GmbH & Co. KG Schönefeld, Germany 100
Zweite K-W-A Beteiligungsgesellschaft mbH Leverkusen, Germany 100
Last updated: February 28, 2014  Copyright © Bayer AG
http://www.geschaeftsbericht2013.bayer.de